Vitrolife AB
Vitrolife EU Taxonomy Data Preview
In 2024, Vitrolife was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Vitrolife has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Vitrolife are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Taxonomy Aligned A1 Turnover | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Eligible A Turnover | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Non-Eligible B Turnover | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Taxonomy Aligned A1 Opex | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Eligible A Opex | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Non-Eligible B Opex | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Taxonomy Aligned A1 Capex | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Eligible A Capex | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Taxonomy Non-Eligible B Capex | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected EU Taxonomy data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Vitrolife's Revenues from Sustainable Activities
In 2024, Vitrolife reported EU Taxonomy-eligible revenues of SEK 352.40 million, representing 10% of its total turnover. Of this amount, SEK 352.40 million of Vitrolife's revenues was classified as EU Taxonomy-aligned, indicating that 10% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).
How much of Vitrolife's revenue is eligible under the EU Taxonomy?
In 2024, Vitrolife reported that SEK 352.40 million of its revenue was eligible under the EU Taxonomy, representing 10% of the company's total turnover. Of this amount, SEK 352.40 million (10% of total revenue) was classified as Taxonomy-aligned. This means that 0% of Vitrolife's revenue is eligible but not aligned, indicating that these activities did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards.
How much of Vitrolife's eligible revenue is aligned with the EU Taxonomy?
In 2024, Vitrolife reported that SEK 352.40 million of its revenue was aligned under the EU Taxonomy, representing 10% of its total turnover.
This moderate level of alignment indicates that Vitrolife has begun shifting toward more sustainable operations but still has considerable room to enhance its green offerings.
Vitrolife's Eligibility & Alignment Overview
Vitrolife's Contribution to Environmental Objectives
- Total Taxonomy Aligned A1 Turnover
- Total Taxonomy Eligible but Not Aligned A2 Turnover
How is Vitrolife's taxonomy-aligned revenue distributed across the EU environmental objectives?
In 2024, Vitrolife reported that its taxonomy-aligned revenue was distributed across the following EU environmental objectives:
- Climate Change Mitigation: 0%
- Climate Change Adaptation: 0%
- Sustainable Use and Protection of Water and Marine Resources: 0%
- Transition to a Circular Economy: 10%
- Pollution Prevention and Control: 0%
- Protection and restoration of biodiversity and ecosystems: 0%
How much revenue does Vitrolife earn from selling climate-related solutions ?
In 2024, Vitrolife reported that SEK 0 of its total revenue was associated with activities contributing to the EU taxonomy climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This accounted for 0% of the company's total revenue, indicating that Vitrolife has limited exposure on solutions that support climate action through its commercial activities.
Insights into Vitrolife's CAPEX from Sustainable Activities
In 2024, Vitrolife reported EU Taxonomy-eligible CAPEX of SEK 106.70 million, representing 26% of its total CAPEX. Of this amount, SEK 45.50 million of Vitrolife's CAPEX was classified as EU Taxonomy-aligned, indicating that 11% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).
How much of Vitrolife's capital expenditure (CAPEX) is eligible under the EU Taxonomy?
In 2024, Vitrolife reported that SEK 106.70 million of its capital expenditure (CAPEX) was eligible under the EU Taxonomy, representing 26% of the company's total CAPEX. Of this amount, SEK 45.50 million (11% of total CAPEX) was classified as Taxonomy-aligned. This means that 15% of Vitrolife's CAPEX is eligible but not aligned, indicating that these investments either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).
How much of Vitrolife's eligible CAPEX is aligned with the EU Taxonomy?
In 2024, Vitrolife reported that SEK 45.50 million of its CAPEX was aligned under the EU Taxonomy, representing 11% of its total capital investment.
This moderate level of alignment indicates that Vitrolife is beginning to transition its capital allocation toward greener investments, but still retains substantial opportunities for further alignment with sustainability goals.
Vitrolife's Eligibility & Alignment Overview
Vitrolife's Contribution to Environmental Objectives
- Total Taxonomy Aligned A1 Capex
- Total Taxonomy Eligible but Not Aligned A2 Capex
How is Vitrolife's taxonomy-aligned CAPEX distributed across the EU environmental objectives?
In 2024, Vitrolife reported that its taxonomy-aligned capital expenditure (CAPEX) was distributed across the following EU environmental objectives:
- Sustainable Use and Protection of Water and Marine Resources: 0%
- Transition to a Circular Economy: 6%
- Pollution Prevention and Control: 0%
- Protection and restoration of biodiversity and ecosystems: 0%
How much Vitrolife is investing in climate-related solutions?
In 2024, Vitrolife allocated SEK 0 of its CAPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 0% of the company's total capital expenditure, indicating that Vitrolife has only marginally directed its capital expenditure toward climate-related activities, suggesting limited alignment with climate objectives.
Insights into Vitrolife's OPEX from Sustainable Activities
In 2024, Vitrolife reported EU Taxonomy-eligible OPEX of SEK 40.50 million, representing 27% of its total operating expenses (OPEX). Of this amount, SEK 40.50 million of Vitrolife's OPEX was classified as EU Taxonomy-aligned, indicating that 27% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).
How much of Vitrolife's operational expenditure (OPEX) is eligible under the EU Taxonomy?
In 2024, Vitrolife reported that SEK 40.50 million of its operational expenditure (OPEX) was eligible under the EU Taxonomy, representing 27% of the company's total OPEX. Of this amount, SEK 40.50 million (27% of total OPEX) was classified as Taxonomy-aligned. This means that 0% of Vitrolife's OPEX is eligible but not aligned, indicating that these expenditures either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).
How much of Vitrolife's eligible OPEX is aligned with the EU Taxonomy?
In 2024, Vitrolife reported that SEK 40.50 million of its OPEX was aligned under the EU Taxonomy, representing 27% of its total operational expenditure.
This moderate level of alignment indicates that Vitrolife is beginning to shift operational priorities toward greener practices, with room for deeper integration.
Vitrolife's Eligibility & Alignment Overview
Vitrolife's Contribution to Environmental Objectives
- Total Taxonomy Aligned A1 Opex
- Total Taxonomy Eligible but Not Aligned A2 Opex
How is Vitrolife's taxonomy-aligned OPEX distributed across the EU environmental objectives?
In 2024, Vitrolife reported that its taxonomy-aligned operational expenditure (OPEX) was distributed across the following EU environmental objectives:
- Climate Change Mitigation: 0%
- Climate Change Adaptation: 0%
- Sustainable Use and Protection of Water and Marine Resources: 0%
- Transition to a Circular Economy: 27%
- Pollution Prevention and Control: 0%
- Protection and restoration of biodiversity and ecosystems: 0%
How much of Vitrolife's operational budget supports climate-related solutions?
In 2024, Vitrolife allocated SEK 0 of its OPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 0% of the company's total OPEX, indicating that Vitrolife has only a limited share of operational expenditure aligned with climate goals, signaling early-stage or minimal integration of climate objectives into its routine activities.